Enzo Biochem, Inc. (NYSE:ENZ)
CAPS Rating:
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.
RSS Headlines
Fool UK
Recs
US District Court ruled against this bio-chemical company in a patent infringement case brought by this company. The six disputed patents relate to the company's method and materials for detecting nucleic acid sequences. Lost $5